The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Sponsor
Canadian Critical Care Trials Group (Other)
Overall Status
Completed
CT.gov ID
NCT00474656
Collaborator
Canadian Institutes of Health Research (CIHR) (Other), McMaster University (Other), University of Toronto (Other)
94
12
18
7.8
0.4

Study Details

Study Description

Brief Summary

Acute respiratory distress syndrome (ARDS) is a common and catastrophic complication of critical illness related to burns, motor vehicle accidents, or overwhelming infection. ARDS kills 40-70% of affected patients. Patients with ARDS require life support in the form of a ventilator to breathe for them while their lungs heal. Ironically, ventilators can cause further damage to the lungs. We are conducting a study comparing 2 methods to protect the lungs from further damage. One method uses standard mechanical ventilators and the other uses a new type of ventilator, called a high frequency oscillator. We propose to test whether this high frequency oscillation will reduce the relative risk of dying from ARDS. 72 patients from 12 intensive care units in Canada and Saudi Arabia will participate in this preliminary study to test the feasibility of our study methods. If feasible, we plan to move on and conduct a large multinational study to definitively answer this question.

Condition or Disease Intervention/Treatment Phase
  • Device: High-frequency oscillation
  • Device: Conventional lung-open mechanical ventilation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
94 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study
Study Start Date :
Jun 1, 2007
Actual Primary Completion Date :
Jul 1, 2008
Actual Study Completion Date :
Dec 1, 2008

Outcome Measures

Primary Outcome Measures

  1. adherence to our explicit mechanical ventilation protocols; [duration of mechanical ventilation]

  2. to measure and understand the reasons for crossovers between groups [duration of mechanical ventilation]

  3. to estimate the rate of patient recruitment, and understand barriers to recruitment []

  4. to document our ability to achieve close to complete follow-up for mortality and quality of life in the 6 months following enrolment []

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients of either sex, 16 years and above;

  • Acute onset of respiratory failure, with fewer than 2 weeks of new pulmonary symptoms;

  • Endotracheal intubation or tracheostomy;

  • Hypoxaemia - defined as a PaO2/FiO2 ≤ 200 mm Hg;

  • Bilateral alveolar consolidation (airspace disease) seen on frontal chest radiograph

Exclusion Criteria:
  • Remaining duration of mechanical ventilation < 48 hours, as judged by the attending physician;

  • Primary cause of acute respiratory failure judged by attending physician to be cardiac in origin;

  • Lack of commitment to ongoing life support;

  • Weight < 35 kg;

  • Severe chronic respiratory disease

  • Morbid obesity - defined as > 1 kg / cm body height;

  • Neurological conditions with risk of intracranial hypertension (hypercapnia should be avoided);

  • Neuromuscular disease that will result in prolonged need for mechanical ventilation;

  • Previous enrolment in this trial;

  • All inclusion criteria present for > 72 hours;

  • On HFO at the time of screening.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alberta Medical Centre Edmonton Alberta Canada
2 Royal Columbian Hospital New Westminster British Columbia Canada
3 St Paul's Hospital Vancouver British Columbia Canada
4 Vancouver General Hospital Vancouver British Columbia Canada
5 Hamilton Health Sciences Hamilton Ontario Canada
6 St. Joseph's Hospital Hamilton Ontario Canada
7 Ottawa Hospital Ottawa Ontario Canada
8 Mt Sinai Hospital Toronto Ontario Canada
9 St Michael's Hospital Toronto Ontario Canada
10 Sunnybrook Health Science Centre Toronto Ontario Canada
11 University Health Network Toronto Ontario Canada
12 King Fahad National Guard Hospital Riyadh Saudi Arabia

Sponsors and Collaborators

  • Canadian Critical Care Trials Group
  • Canadian Institutes of Health Research (CIHR)
  • McMaster University
  • University of Toronto

Investigators

  • Principal Investigator: Niall D Ferguson, MD, MSc, University of Toronto
  • Principal Investigator: Maureen O Meade, MD, MSc, McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00474656
Other Study ID Numbers:
  • 164451
First Posted:
May 17, 2007
Last Update Posted:
Jan 30, 2009
Last Verified:
Jan 1, 2009

Study Results

No Results Posted as of Jan 30, 2009